封面
市场调查报告书
商品编码
1477183

药品折扣卡市场按类型、治疗类别、配销通路、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Drug Discount Card Market By Type, By Therapeutic Category, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年药品折扣卡市场规模为 17.1621 亿美元,2024 年至 2032 年复合年增长率为 8.5%。

药品折扣卡市场-市场动态

处方药成本上涨推动药品折扣卡市场激增

消费者越来越多地使用这些卡片来减轻与购买药物相关的经济负担,尽可能寻求折扣和节省。根据国家医学图书馆的数据,2022年,美国处方药总体支出增加了4.0%至6.0%。随着处方药成本持续攀升,对负担得起的替代品的需求推动了药品折扣卡市场的激增。处方药价格不断上涨已成为市场扩张的重要推动力,凸显了对可用解决方案的迫切需求,以减轻医疗费用上涨对个人和家庭的影响。

药品折扣卡市场 - 主要见解

根据我们的研究分析师分享的分析,预计全球市场在预测期内(2024-2032 年)每年将以 8.5% 左右的复合年增长率成长

根据类型细分,预计通用卡将在 2023 年显示最大的市场份额

依治疗类别细分,2023年抗癌药物为主导类型

从配销通路细分来看,2023年线上为主导类型

按地区划分,北美是 2023 年的主要收入来源

药品折扣卡市场-細項分析:

全球药品折扣卡市场根据类型、治疗类别、配销通路和地区进行细分。

市场依类型分为两类:在类型类别下,市场分为品牌卡和通用卡,代表提供处方药折扣的不同方法。品牌卡通常为品牌药物提供折扣,而通用卡则专注于为通用药物提供折扣。

根据治疗类别,市场分为四个类别: 在治疗类别细分方面,市场根据折扣卡涵盖的药物类型进行细分。这包括对于控制血糖水平至关重要的糖尿病药物;止痛药有助于缓解不适和控制慢性疼痛,对于治疗各种类型的癌症至关重要。

药品折扣卡市场 - 地理洞察

从地理来看,该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

在北美,尤其是美国,市场高度发达,并受到处方药成本上涨的推动,导致折扣卡计划被广泛采用。由于医疗保健成本增加以及改善获得负担得起的药物的机会的推动,欧洲对药品折扣卡的需求也不断增长。在印度和中国等新兴经济体,由于医疗保健意识不断提高以及对具有成本效益的医疗保健解决方案的需求,市场正在迅速扩大。

药品折扣卡市场-竞争格局:

药品折扣卡市场竞争格局的特征是多元化的参与者争夺市场份额。主要利害关係人包括製药公司、连锁药局、医疗保健技术公司和专业折扣卡提供者。大型製药公司经常提供品牌药品折扣卡,作为患者援助计划的一部分,以提高药物取得和品牌忠诚度。药房连锁店利用其广泛的网络来分发折扣卡并吸引顾客。

最近的发展:

2023 年 9 月,Elevance 推出了 CarelonRx,这是一项新计划,旨在让会员更轻鬆地在药房柜檯获得药品折扣。 CarelonRx 提供药物补充、更新、定价以及送货上门的数位工具。

目录

第 1 章:药品折扣卡市场概述

  • 研究范围
  • 市场预估年份

第 2 章:执行摘要

  • 市场片段
    • 按类型分類的药品折扣卡市场片段
    • 按治疗类别分類的药物折扣卡市场片段
    • 按配销通路分類的药品折扣卡市场片段
    • 按国家/地区分類的药品折扣卡市场片段
    • 按地区分類的药品折扣卡市场片段
  • 竞争洞察

第 3 章:药品折扣卡主要市场趋势

  • 药品折扣卡市场驱动因素
    • 市场驱动因素的影响分析
  • 药品折扣卡市场限制
    • 市场限制影响分析
  • 药品折扣卡市场机会
  • 药品折扣卡市场未来趋势

第 4 章:药品折扣卡产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章:药品折扣卡市场:COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章:药品折扣卡市场格局

  • 2023 年药品折扣卡市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章:药品折扣卡市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 品牌卡
    • 通用卡

第 8 章:药品折扣卡市场 - 按治疗类别

  • 概述
    • 按治疗类别分類的细分市场份额分析
    • 糖尿病药物
    • 止痛药
    • 心理健康药物
    • 癌症药物
    • 其他的

第 9 章:药品折扣卡市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 离线
    • 在线的

第 10 章:药品折扣卡市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 药品折扣卡北美主要製造商
    • 北美市场规模和预测(按国家)
    • 北美市场规模和预测(按类型)
    • 北美市场规模和预测(按治疗类别)
    • 北美市场规模和预测(按配销通路)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 药品折扣卡欧洲主要製造商
    • 欧洲市场规模和预测(按国家)
    • 欧洲市场规模与预测(按类型)
    • 欧洲市场规模和预测(按治疗类别)
    • 欧洲市场规模和预测(按配销通路)
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 药品折扣卡亚太地区主要製造商
    • 亚太地区市场规模与预测(按国家)
    • 亚太地区市场规模与预测(按类型)
    • 亚太地区市场规模和预测(按治疗类别)
    • 亚太地区市场规模和预测(按配销通路)
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 药品折扣卡拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测(按国家)
    • 拉丁美洲市场规模与预测(按类型)
    • 拉丁美洲市场规模和预测(按治疗类别)
    • 拉丁美洲市场规模和预测(按配销通路)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 药品折扣卡中东和非洲主要製造商
    • 中东和非洲市场规模及预测(按国家)
    • 中东和非洲市场规模及预测(按类型)
    • 中东和非洲市场规模及预测(按治疗类别)
    • 中东和非洲市场规模及预测(按配销通路)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章:主要供应商分析 - 药品折扣卡产业

  • 竞争仪表板
  • 公司简介
    • GoodRx
    • SingleCare
    • WellCard Savings
    • RxSaver
    • Optum Perks
    • Kroger Prescription Savings Club
    • ScriptSave
    • Walmart Rx Savings Program
    • Prescription Hope
    • FamilyWize
    • NeedyMeds
    • Humana
    • AARP Prescription Discounts (UnitedHealth Group)
    • Blink Health
    • Coast2Coast Rx
    • HealthWarehouse.com, Inc.
    • Inside Rx (Express Scripts)
    • Simple Savings Card
    • United Networks of America
    • USA Rx
    • Watertree Health
    • Others

第 12 章:360 度分析师视角

第 13 章:附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2581

REPORT HIGHLIGHT

Drug Discount Card Market size was valued at USD 1,716.21 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

The Drug Discount Card Market provides consumers with discounted prices on prescription medications through various platforms or programs. The rapid expansion of digital platforms and mobile applications offers convenient access to discounts and medication information. However, the market faces restraints such as regulatory complexities, varying discount regulations across regions, and concerns regarding data privacy and security. The increasing demand for affordable medications, especially among underserved populations, and the potential for partnerships with healthcare stakeholders to enhance patient outcomes is an opportunity for the market.

Drug Discount Card Market- Market Dynamics

Rising prescription drug costs fuel the surge in the drug discount card market

Consumers are increasingly turning to these cards to alleviate the financial burden associated with purchasing medications, seeking discounts and savings wherever possible. According to the National Library of Medicine, in 2022, the overall prescription drug spending has risen by 4.0% to 6.0% in the United States. As prescription drug costs continue to climb, the demand for affordable alternatives has propelled a surge in the Drug Discount Card Market. The escalating prices of prescription drugs have become a significant driver in the market's expansion, highlighting the critical need for accessible solutions to mitigate the impact of rising healthcare expenses on individuals and families.

Drug Discount Card Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, Generic card was predicted to show maximum market share in the year 2023

Based on Therapeutic Category segmentation, Cancer drugs were the leading type in 2023

Based on Distribution Channel segmentation, online was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Drug Discount Card Market- Segmentation Analysis:

The Global Drug Discount Card Market is segmented based on Type, Therapeutic Category, Distribution Channel, and Region.

The market is divided into two categories based on Type: Under the type category, the market is divided into Branded Cards and Generic Cards, representing distinct approaches to providing discounts on prescription medications. Branded Cards typically offer discounts on brand-name drugs, while Generic Cards focus on providing savings for generic medications.

The market is divided into four categories based on Therapeutic Category: In terms of therapeutic category segmentation, the market is segmented based on the types of medications covered by the discount cards. This includes Diabetes drugs, which are crucial for managing blood sugar levels; Pain medications, which help alleviate discomfort and manage chronic pain conditions and are essential for treating various types of cancer.

Drug Discount Card Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

In North America, particularly in the United States, the market is highly developed and driven by the rising cost of prescription drugs, leading to the widespread adoption of discount card programs. Europe also exhibits a growing demand for drug discount cards, fueled by increasing healthcare costs and efforts to improve access to affordable medications. In emerging economies such as India and China, the market is expanding rapidly due to rising healthcare awareness and the need for cost-effective healthcare solutions.

Drug Discount Card Market- Competitive Landscape:

The competitive landscape of the Drug Discount Card Market is characterized by a diverse range of players vying for market share. Key stakeholders include pharmaceutical companies, pharmacy chains, healthcare technology firms, and specialized discount card providers. Major pharmaceutical companies often offer branded drug discount cards as part of patient assistance programs to enhance medication access and brand loyalty. Pharmacy chains leverage their extensive networks to distribute discount cards and attract customers.

Recent Developments:

In September 2023, Elevance launched CarelonRx, a new program that aims to make it easier for members to access drug discounts at the pharmacy counter. CarelonRx offers digital tools for medication refilling, renewal, and pricing, as well as home delivery.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG DISCOUNT CARD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GoodRx

SingleCare

WellCard Savings

RxSaver

Optum Perks

Kroger Prescription Savings Club

ScriptSave

Walmart Rx Savings Program

Prescription Hope

FamilyWize

NeedyMeds

Humana

AARP Prescription Discounts (UnitedHealth Group)

Blink Health

Coast2Coast Rx

HealthWarehouse.com, Inc.

Inside Rx (Express Scripts)

Simple Savings Card

United Networks of America

USA Rx

Watertree Health

Others

GLOBAL DRUG DISCOUNT CARD MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Branded Cards
  • Generic Cards

GLOBAL DRUG DISCOUNT CARD MARKET, BY THERAPEUTIC CATEGORY- MARKET ANALYSIS, 2019 - 2032

  • Diabetes drugs
  • Pain medications
  • Mental health medications
  • Cancer drugs
  • Others

GLOBAL DRUG DISCOUNT CARD MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Offline
  • Online

GLOBAL DRUG DISCOUNT CARD MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Drug Discount Card Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Drug Discount Card Market Snippet by Type
    • 2.1.2.Drug Discount Card Market Snippet by Therapeutic Category
    • 2.1.3.Drug Discount Card Market Snippet by Distribution Channel
    • 2.1.4.Drug Discount Card Market Snippet by Country
    • 2.1.5.Drug Discount Card Market Snippet by Region
  • 2.2.Competitive Insights

3.Drug Discount Card Key Market Trends

  • 3.1.Drug Discount Card Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Drug Discount Card Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Drug Discount Card Market Opportunities
  • 3.4.Drug Discount Card Market Future Trends

4.Drug Discount Card Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Drug Discount Card Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Drug Discount Card Market Landscape

  • 6.1.Drug Discount Card Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Drug Discount Card Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Branded Cards
    • 7.1.3.Generic Cards

8.Drug Discount Card Market - By Therapeutic Category

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Therapeutic Category, 2023 & 2032 (%)
    • 8.1.2.Diabetes drugs
    • 8.1.3.Pain medications
    • 8.1.4.Mental health medications
    • 8.1.5.Cancer drugs
    • 8.1.6.Others

9.Drug Discount Card Market - By Distribution Channel

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2.Offline
    • 9.1.3.Online

10.Drug Discount Card Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Drug Discount Card Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Drug Discount Card Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Drug Discount Card Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Drug Discount Card Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Drug Discount Card Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Therapeutic Category, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Drug Discount Card Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.GoodRx
    • 11.2.2.SingleCare
    • 11.2.3.WellCard Savings
    • 11.2.4.RxSaver
    • 11.2.5.Optum Perks
    • 11.2.6.Kroger Prescription Savings Club
    • 11.2.7.ScriptSave
    • 11.2.8.Walmart Rx Savings Program
    • 11.2.9.Prescription Hope
    • 11.2.10.FamilyWize
    • 11.2.11.NeedyMeds
    • 11.2.12.Humana
    • 11.2.13.AARP Prescription Discounts (UnitedHealth Group)
    • 11.2.14.Blink Health
    • 11.2.15.Coast2Coast Rx
    • 11.2.16.HealthWarehouse.com, Inc.
    • 11.2.17.Inside Rx (Express Scripts)
    • 11.2.18.Simple Savings Card
    • 11.2.19.United Networks of America
    • 11.2.20.USA Rx
    • 11.2.21.Watertree Health
    • 11.2.22.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Drug Discount Card Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Drug Discount Card Market, by Type 2019-2032 (USD Million)
  • TABLE Drug Discount Card Market: Therapeutic Category Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Category
  • TABLE Global Drug Discount Card Market, by Therapeutic Category 2019-2032 (USD Million)
  • TABLE Drug Discount Card Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Drug Discount Card Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Drug Discount Card Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Drug Discount Card Market, by Region 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE North America Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Europe Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Latin America Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Therapeutic Category, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug Discount Card Market, by Distribution Channel, 2019-2032 (USD Million)